Inhibrx Biosciences Statistics
NASDAQ: INBXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
68.97-5.36 (-7.21%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Inhibrx Biosciences by the numbers
Inhibrx Biosciences has a market capitalization of $1.02 billion based on 14.77M shares outstanding. With trailing EPS of $-9.06, Inhibrx Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.4% below its 50-day average and 25.4% below its 200-day average.
Average daily trading volume is 305.96K shares, or about $21.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
INBX valuation vs. peer median
| Metric | INBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.02B | $846.91M | +20% |
| Avg. volume | 305.96K | 954.21K | -68% |
Peer median across 8 companies: IMTX, VOR, TSHA, ODTX, BBTX, NVAX, PRME, MGTX.
Valuation
- Market cap
- $1.02B
- Price / sales (latest FY)
- 783.56
- EPS (TTM)
- $-9.06
- Shares outstanding
- 14.77M
Price and trading
- Previous close
- 74.33
- Open
- 72.72
- Day range
- 68.78 – 74.45
- 52-week range
- 57.30 – 155.29
- 52-week change
- -17.82%
- Beta
- —
- Volume
- 252.13K
- Average volume
- 305.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 1.02B
- Forward Pe
- -8.20
- Eps
- -9.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 155.29
- Week52 Low
- 57.30
- Avg Volume
- 305.96K
- Shares Outstanding
- 14.77M
- Ma50
- 91.17
- Ma200
- 92.47
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -55.59%
- Pct From52w Low
- 20.37%